Article
Medicine, Research & Experimental
Jose Israel Leon-Pedroza, Octavio Rodriguez-Cortes, Raul Flores-Mejia, Cinthia Vianney Gaona-Aguas, Antonio Gonzalez-Chavez
Summary: This study evaluated the impact of MetS components combinations on the risk of death among COVID-19 patients. It found that the presence of one MetS component doubles the risk of death, with patients having DM2 + hypertension showing a higher risk, while there was no significant interaction between obesity and CVD.
ARCHIVES OF MEDICAL RESEARCH
(2021)
Review
Cardiac & Cardiovascular Systems
Gregory J. Grosicki, Kanokwan Bunsawat, Soolim Jeong, Austin T. Robinson
Summary: Racial and ethnic-related health disparities in the United States have been exacerbated by the COVID-19 pandemic, with minority populations at higher risk for severe illness and death. Social determinants of health play a critical role in explaining these disparities among non-Hispanic Black and Hispanic/Latinx individuals compared to non-Hispanic White individuals.
PROGRESS IN CARDIOVASCULAR DISEASES
(2022)
Article
Endocrinology & Metabolism
Sabrina E. Racine-Brzostek, He S. Yang, Gwendolyne A. Jack, Zhengming Chen, Amy Chadburn, Thomas J. Ketas, Erik Francomano, P. J. Klasse, John P. Moore, Kathleen A. McDonough, Roxanne C. Girardin, Alan P. Dupuis, Anne F. Payne, Lucy X. Ma, Jacob Sweeney, Elaine Zhong, Jim Yee, Melissa M. Cushing, Zhen Zhao
Summary: Postconvalescent SARS-CoV-2 IgG and neutralizing antibodies are elevated in obese patients, and there is a positive correlation between BMI and antibody levels.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
(2021)
Review
Cardiac & Cardiovascular Systems
Rika Kawakami, Atsushi Sakamoto, Kenji Kawai, Andrea Gianatti, Dario Pellegrini, Ahmed Nasr, Bob Kutys, Liang Guo, Anne Cornelissen, Masayuki Mori, Yu Sato, Irene Pescetelli, Matteo Brivio, Maria Romero, Giulio Guagliumi, Renu Virmani, Aloke V. Finn
Summary: Myocarditis is rare in COVID-19 patients, with virus detected in the heart in only a few cases. Myocarditis may be caused by macrophages and T cells, but it does not represent clinically relevant myocarditis.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
(2021)
Letter
Immunology
Amy K. Feehan, Cruz Velasco, Daniel Fort, Jeffrey H. Burton, Eboni G. Price-Haywood, Peter T. Katzmarzyk, Julia Garcia-Diaz, Leonardo Seoane
Summary: By using paired molecular and antibody testing for severe acute respiratory syndrome coronavirus 2 infection, the study in Louisiana, USA during the second phase of reopening found highly variable infections by race and ethnicity, work environment, and ZIP code. Census-weighted seroprevalence was 3.6%, and point prevalence was 3.0%.
EMERGING INFECTIOUS DISEASES
(2021)
Article
Cardiac & Cardiovascular Systems
Brittany D. Brumback, Oleksandr Dmytrenko, Ashley N. Robinson, Adam L. Bailey, Pan Ma, Jing Liu, Stephanie C. Hicks, Sherwin Ng, Gang Li, David M. Zhang, Catherine E. Lipovsky, Chieh-Yu Lin, Michael S. Diamond, Kory J. Lavine, Stacey L. Rentschler
Summary: COVID-19 is associated with serious cardiovascular complications, and this study demonstrates that human cardiac pericytes are susceptible to SARS-CoV-2 infection. Viral entry into pericytes is mediated by endosomal proteases, leading to up-regulation of inflammatory markers and cell death. Evidence of cardiac pericyte infection was also found in COVID-19 myocarditis patients, suggesting a potential role for pericyte infection in COVID-19.
JACC-BASIC TO TRANSLATIONAL SCIENCE
(2023)
Review
Immunology
Kei Sato, Jane E. Sinclair, Habib Sadeghirad, John F. Fraser, Kirsty R. Short, Arutha Kulasinghe
Summary: Pre-existing cardiovascular disease increases the morbidity and mortality of COVID-19, while SARS-CoV-2 infection can also trigger acute and chronic cardiovascular disease. Acute cardiac complications such as arrhythmia, myocarditis, and heart failure are significantly associated with higher in-hospital mortality. The long-term cardiac complications of COVID-19 include hypertension, arrhythmia, coronary atherosclerosis, and heart failure, but the impact of these complications on long-term patient health remains unclear.
CLINICAL & TRANSLATIONAL IMMUNOLOGY
(2021)
Review
Medicine, General & Internal
Nina Filip, Elena Cojocaru, Oana Viola Badulescu, Andreea Clim, Alin Constantin Pinzariu, Gabriela Bordeianu, Alina Elena Jehac, Cristina Elena Iancu, Cristiana Filip, Minela Aida Maranduca, Ivona Andreea Sova, Ionela Lacramioara Serban
Summary: Since December 2019, the spread of SARS-CoV-2 has caused global instability. COVID-19 patients with comorbidities such as cardiovascular disease and diabetes are more severe. Thrombosis is a serious complication, and homocysteine is considered a potential marker for it. This review aims to analyze the involvement of homocysteine in COVID-19 and its correlation with disease severity.
Article
Cardiac & Cardiovascular Systems
Eric Yuk Fai Wan, Sukriti Mathur, Ran Zhang, Vincent Ka Chun Yan, Francisco Tsz Tsun Lai, Celine Sze Ling Chui, Xue Li, Carlos King Ho Wong, Esther Wai Yin Chan, Kai Hang Yiu, Ian Chi Kei Wong
Summary: This study aims to evaluate the short- and long-term associations between COVID-19 and development of cardiovascular disease (CVD) outcomes and mortality. The study found that COVID-19 infection is associated with significantly increased short- and long-term risks of CVD and mortality.
CARDIOVASCULAR RESEARCH
(2023)
Article
Endocrinology & Metabolism
Jacob V. Stidsen, Anders Green, Louise Rosengaard, Kurt Hojlund
Summary: COVID-19 increases the risk of hospitalization and death in patients with diabetes and diabetes-related conditions. This study examined the trends in COVID-19-related hospitalization and mortality in the Danish population. The risk of hospitalization increased more in patients with diabetes compared to those without diabetes. However, the overall mortality rate did not change significantly due to reduced mortality among hospitalized patients with diabetes.
FRONTIERS IN ENDOCRINOLOGY
(2022)
Article
Endocrinology & Metabolism
Martina Recalde, Andrea Pistillo, Sergio Fernandez-Bertolin, Elena Roel, Maria Aragon, Heinz Freisling, Daniel Prieto-Alhambra, Edward Burn, Talita Duarte-Salles
Summary: The study revealed a positive association between BMI and the risks of COVID-19 diagnosis and hospitalization, while a J-shaped relationship with mortality was observed, particularly among younger patients. Further research is needed to understand the mechanisms underlying these relationships.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
(2021)
Article
Immunology
Nick Eichler, Craig Thomley, Tara Swadi, Tom Devine, Caroline McElnay, Jillian Sherwood, Cheryl Brunton, Felicity Williamson, Josh Freeman, Sarah Berger, Xiaoyun Ren, Matt Storey, Joep de Ligt, Jemma L. Geoghegan
Summary: The strategy in New Zealand to eliminate coronavirus disease involves managed isolation and quarantine, mandatory testing for international arrivals, and integrating genomic and epidemiologic data to investigate virus transmission pathways. This approach identified a multibranched chain of transmission including on flights and a probable case of aerosol transmission without direct person-to-person contact, highlighting the power of combining genomic and epidemiologic data for outbreak investigations.
EMERGING INFECTIOUS DISEASES
(2021)
Review
Nutrition & Dietetics
Elaine A. Yu, Rachael P. Jackman, Marshall J. Glesby, K. M. Venkat Narayan
Summary: Cardiometabolic diseases have been found to be associated with COVID-19 severity, but the specific mechanisms are unclear. Studies have shown that obesity is related to higher neutralizing antibody titers after SARS-CoV-2 infection, while diabetes, hypertension, and cardiovascular diseases are not associated with antibody levels.
ADVANCES IN NUTRITION
(2023)
Article
Health Care Sciences & Services
Carles Perpinan, Laia Bertran, Ximena Terra, Carmen Aguilar, Miguel Lopez-Dupla, Ajla Alibalic, David Riesco, Javier Camaron, Francesco Perrone, Anna Rull, Laia Reverte, Elena Yeregui, Anna Marti, Francesc Vidal, Teresa Auguet
Summary: This study found that obesity and metabolic syndrome can impact the clinical course of COVID-19 in patients, requiring intensified and personalized treatment. In particular, biomarkers such as IL-6, troponin, and LDH may serve as predictors of disease severity in patients with obesity or MS.
JOURNAL OF PERSONALIZED MEDICINE
(2021)
Article
Biology
Elizabeth Griggs, Kyle Trageser, Sean Naughton, Eun-Jeong Yang, Brian Mathew, Grace Van Hyfte, Linh Hellmers, Nathalie Jette, Molly Estill, Li Shen, Tracy Fischer, Giulio Maria Pasinetti
Summary: Infection with SARS-CoV-2, the causative agent of COVID-19, can affect cognition in some patients with post-acute sequelae of SARS-CoV-2. This study examines the neuropathophysiological consequences of SARS-CoV-2 infection and finds similar alterations in neuroinflammation and blood-brain barrier integrity in individuals with SARS-CoV-2, Alzheimer's disease, and SARS-CoV-2-infected Alzheimer's disease. The findings may have implications for therapeutic treatments in patients with neuro-PASC, especially those at risk of developing Alzheimer's disease.
Editorial Material
Neurosciences
Soolim Jeong, Kamila U. Pollin, Lyndsey E. DuBose, Kanokwan Bunsawat
JOURNAL OF PHYSIOLOGY-LONDON
(2022)
Review
Cardiac & Cardiovascular Systems
Gregory J. Grosicki, Kanokwan Bunsawat, Soolim Jeong, Austin T. Robinson
Summary: Racial and ethnic-related health disparities in the United States have been exacerbated by the COVID-19 pandemic, with minority populations at higher risk for severe illness and death. Social determinants of health play a critical role in explaining these disparities among non-Hispanic Black and Hispanic/Latinx individuals compared to non-Hispanic White individuals.
PROGRESS IN CARDIOVASCULAR DISEASES
(2022)